Goldman Sachs
COV

Goldman Sachs’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Goldman Sachs’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-26,100
Closed -$2.67M – 7612
2014
Q4 		$2.67M Sell
26,100
-65,800
-72% -$6.31M ﹤0.01% 3556
2014
Q3 		$7.95M Sell
91,900
-18,800
-17% -$1.67M ﹤0.01% 2564
2014
Q2 		$9.98M Buy
110,700
+17,800
+19% +$1.33M ﹤0.01% 2369
2014
Q1 		$6.84M Buy
92,900
+16,200
+21% +$1.13M ﹤0.01% 2703
2013
Q4 		$5.22M Sell
76,700
-86,700
-53% -$5.64M ﹤0.01% 3035
2013
Q3 		$9.96M Buy
163,400
+74,062
+83% +$4.52M ﹤0.01% 2254
2013
Q2 		$4.98M Buy
+89,338
New +$5.17M ﹤0.01% 2748

Goldman Sachs's COV Position: Q1 2015 in Review

Goldman Sachs sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,623,849 shares — an estimated $268M sold.

Goldman Sachs first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $269M in Q4 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Goldman Sachs reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 2,623,849 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $268M.
  • Goldman Sachs first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $269M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.